Episode 499: Why ApoB Could Be the Most Important Heart Health Test You're Missing
ApoB isn't just another cholesterol marker—it's the missing key to understanding heart disease risk, according to Dr. Joel Kahn in this pivotal episode of Heart Doc VIP. He argues that measuring ApoB, the structural protein on all atherogenic lipoproteins, is far more accurate than LDL cholesterol alone, because every dangerous particle—LDL, lipoprotein(a), VLDL, IDL—carries exactly one ApoB molecule. Using the vivid analogy of bacon wrapping hot dogs, burgers, and sandwiches, Kahn explains that tracking ApoB is like counting bacon slices: it reveals the true number of plaque-forming particles in your blood. He cites a major new study in *Circulation Research* showing that pharmaceutical companies are now targeting ApoB-lowering therapies because they know it’s a direct path to reducing heart disease. Yet despite being available for 30 years, ApoB testing remains underused. Kahn urges listeners to demand it from their doctors, especially if their LDL is normal but ApoB is high—often a sign of elevated lipoprotein(a), a major genetic risk factor. He also highlights other emerging science: GLP-1 drugs may reduce breast cancer risk by 30%, melatonin boosts DNA repair in shift workers, and Pilates lowers blood pressure and improves autonomic function. But the real takeaway? If you're serious about heart health, ApoB is the single most important test you're likely missing.
Track ApoB, not just LDL cholesterol—every atherogenic particle has one ApoB molecule, making it the most accurate measure of heart disease risk.
ApoB levels under 60 mg/dL are ideal for high-risk patients (e.g., post-heart attack, high calcium score), with 50–30 mg/dL as a target for aggressive prevention.
If your LDL is normal but ApoB is high, you likely have elevated lipoprotein(a)—a major genetic risk factor that requires specific testing and management.
ApoB testing is inexpensive, widely available, and should be added to every cholesterol panel—ask your doctor to include it.
Diet, exercise, and plant-based eating lower ApoB naturally; supplements like Vinia may help reduce endothelin-1, a blood vessel constrictor.
…and 3 more takeaways available in PodZeus
Welcome to Episode 499: The Road to 500
Dr. Joel Kahn welcomes listeners to episode 499 of Heart Doc VIP, marking the countdown to episode 500, and introduces upcoming appointments in Michigan and Florida. He promotes iGenus.com as a sponsor, highlighting their clean, high-strength triple vitamin K complex.
GLP-1 Drugs and a 30% Drop in Breast Cancer Risk
“In this database, this was not a prospective randomized study, but breast cancer rates were 30% lower in women taking GLP-1 medication.”
Melatonin Boosts DNA Repair in Shift Workers
“There was essentially twice the rate of indication that the DNA was being repaired to restore them back to good, healthy DNA function in the group that was on melatonin.”
Atrial Fibrillation: Blood Thinners vs. Left Atrial Appendage Closure
“In the left atrial appendage group, 154 patients had bleeding and in the anticoagulation group, 260 patients had bleeding, 260 out of 1,500.”
Why Do We Have Lipoprotein(a)? A Surprising Trade-Off
A study of 27,564 people found that those with undetectable lipoprotein(a) had a slightly higher risk of type 2 diabetes, suggesting a possible evolutionary trade-off: lipoprotein(a) may protect against diabetes but increases heart disease risk.
“This article also made a lot of press the fact that if you look up just one slice of lunch meat in your sandwich, it doesn't have to be in a sandwich, but that's common, is a risk for cancer.”
“So ApoB is the bacon around the hot dog, the bacon around the burger, the bacon around the turkey sandwich. It is the common thread between particles in the blood that are prone to creating plaque.”
“And what was the observation in this database? This was not a prospective randomized study that breast cancer rates were 30 lower. in women taking GLP -1 medication.”
Host
Dr. Joel Kahn
person
iGenus
brand
Circulation Research
other
Vinia
product
Watchman
product
British Medical Journal
other
New England Journal of Medicine
other
Environmental Working Group
organization
Michael Greger
person
American Journal of Clinical Nutrition
other
Episode 498: Do You Want a One and Done Cholesterol Infusion? The Long Road Ahead
31m • 6/2/2026
Episode 500: The Long Path to Building an Integrative Cardiology Practice
31m • 6/16/2026
The Surgeon Defending Statins, GLP-1s, and Ancel Keys | Dr Terry Simpson
1h 42m • 6/1/2026
Nutrition for satiety and weight loss | Dr Federica Amati
1h 33m • 6/9/2026
Wednesday, June 10, 2026
1h 5m • 6/10/2026
Start discovering podcast insights today
Start with a 7-day trial and explore a growing catalog of popular podcasts. No credit card required.
No credit card required • 7-day trial • Cancel anytime

